Search Results

There are 21347 results for: content related to: Use of hepatitis B surface and “e” antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV - HBV

  1. You have free access to this content
    HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 112–119, Jia-Horng Kao

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12400

  2. You have free access to this content
    When can we stop nucleoside analogues in patients with chronic hepatitis B?

    Liver International

    Volume 37, Issue S1, January 2017, Pages: 52–58, Chern Hao Chong and Seng Gee Lim

    Version of Record online : 3 JAN 2017, DOI: 10.1111/liv.13314

  3. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. You have free access to this content
    HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 82–90, Michelle Martinot-Peignoux, Tarik Asselah and Patrick Marcellin

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12735

  5. Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 130–139, François Habersetzer, Rémy Moenne-Loccoz, Nicolas Meyer, Evelyne Schvoerer, Pauline Simo-Noumbissie, Stavros Dritsas, Thomas F. Baumert and Michel Doffoël

    Version of Record online : 15 SEP 2014, DOI: 10.1111/liv.12661

  6. You have free access to this content
    Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 100–106, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12719

  7. Intensification with pegylated interferon during treatment with tenofovir in HIV–hepatitis B virus co-infected patients

    Journal of Viral Hepatitis

    Volume 23, Issue 12, December 2016, Pages: 1017–1026, A. Boyd, L. Piroth, S. Maylin, M. Maynard-Muet, F. Lebossé, C. Bouix, C. Lascoux-Combe, N. Mahjoub, P.-M. Girard, C. Delaugerre, F. Carrat, K. Lacombe and P. Miailhes

    Version of Record online : 3 AUG 2016, DOI: 10.1111/jvh.12581

  8. You have free access to this content
    New therapeutic perspectives in HBV: when to stop NAs

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 146–153, Cristina Pérez-Cameo, Mònica Pons and Rafael Esteban

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12398

  9. You have free access to this content
    The role of HBsAg quantification for monitoring natural history and treatment outcome

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 125–132, Michelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah and Patrick Marcellin

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12075

  10. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  11. Can Quantitative Hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?

    Journal of Viral Hepatitis

    Accepted manuscript online: 14 JUL 2017, Gayatri Chakrabarty, Matthew Bruce, Mary Horner, Bo Wang, Kosh Agarwal and Ivana Carey

    DOI: 10.1111/jvh.12756

  12. You have free access to this content
    Poster Session 4: Stem Cell Biology; Varices and Bleeding

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1195A–1215A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28243

  13. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  14. You have free access to this content
    Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 137–150, Geoffrey Dusheiko

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12078

  15. Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D

    Liver International

    Volume 33, Issue 4, April 2013, Pages: 580–585, Lucio Boglione, Antonio D'Avolio, Giuseppe Cariti, Gabriella Gregori, Elisa Burdino, Lorena Baietto, Jessica Cusato, Valeria Ghisetti, Francesco G. De Rosa and Giovanni Di Perri

    Version of Record online : 14 JAN 2013, DOI: 10.1111/liv.12091

  16. HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy

    Liver International

    Volume 35, Issue 4, April 2015, Pages: 1290–1302, Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, Taito Fukushima, Yusuke Kawamura, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi and Hiromitsu Kumada

    Version of Record online : 28 AUG 2014, DOI: 10.1111/liv.12652

  17. You have free access to this content
    HBsAg quantification: useful for monitoring natural history and treatment outcome

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 97–107, Michelle Martinot-Peignoux, Martine Lapalus, Tarik Asselah and Patrick Marcellin

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12403

  18. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 854–859, James Fung, Wai-kay Seto, Danny Ka-ho Wong, Ching-lung Lai and Man-fung Yuen

    Version of Record online : 4 JUN 2014, DOI: 10.1111/liv.12596

  19. You have free access to this content
    Poster Session 3: Hepatitis B: Epidemiology and Natural History History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 961A–1001A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28233

  20. Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta

    Liver International

    Volume 34, Issue 8, September 2014, Pages: 1207–1215, Gökhan Kabaçam, Heiner Wedemeyer, Berna Savaş, Onur Keskin, George Dalekos, Fehmi Tabak, Ramazan Idilman, Andreas Erhardt, Kendal Yalçın, Mithat A. Bozdayi, Hakan Bozkaya, Michael Manns, Hans Dienes, Cihan Yurdaydın and for the HIDIT-1 Study Group

    Version of Record online : 5 DEC 2013, DOI: 10.1111/liv.12376